nach oben

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Erschienen in:

01.10.2012 | Originalien

Outcome prediction using clinical scores and biomarkers in patients with presumed severe infection in the emergency department

verfasst von: Dr. J. Wilhelm, S. Hettwer, D. Hammer, M. Schürmann, A. Christoph, M. Amoury, T. Klöss, R. Finke, H. Ebelt, K. Werdan

Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin | Ausgabe 7/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Severe infections play an important role in the emergency department (ED) and early risk stratification is essential. We compared the prognostic value of APACHE II, SOFA, and MEDS scores, and the biomarkers C-reactive protein (CRP), procalcitonin (PCT), and interleukin 6 (IL-6).

Methods

We performed a prospective observational study. Patients aged 18 years or older with a severe infection, from whom blood cultures were taken, were included.

Results

Two hundred and eleven patients were included. The 30-day mortality rate was 8.5%. All scores and biomarkers showed significant area under the curve (AUC) values of receiver operating characteristic curve analysis for death within 30 days: 0.801 for APACHE II, 0.785 for MEDS, 0.708 for SOFA, 0.693 for CRP, 0.651 for PCT, and 0.716 for IL-6. For treatment in an ICU and need for mechanical ventilation, these parameters had significant AUC values, too. For renal replacement therapy, only APACHE II, SOFA, and PCT showed significant AUC values. According to the trend observed, the AUC values were highest for the APACHE II score.

Conclusions

All investigated parameters have a predictive value in patients with an infection in the ED. According to the trend observed, the APACHE II score seems to have the best discriminative power. Use of the APACHE II score already at the time of admission to the ED may be useful for stratifying patients at risk for ICU treatment, thereby using the same score in the ED and the ICU.

Akkus MN, Polat G, Yurtdas M et al (2009) Admission levels of C-reactive protein and plasminogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission. Int Heart J 50:33–45PubMedCrossRef

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef

Bouadma L, Luyt CE, Tubach F et al (2010) Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463–474PubMedCrossRef

Chen CC, Chong CF, Liu YL et al (2006) Risk stratification of severe sepsis patients in the emergency department. Emerg Med J 23:281–285PubMedCrossRef

Kruif MD de, Limper M, Gerritsen H et al (2010) Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med 38:457–463PubMedCrossRef

Debrunner M, Schuiki E, Minder E et al (2008) Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 97:298–305PubMedCrossRef

Hausfater P, Juillien G, Madonna-Py B et al (2007) Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 11:R60PubMedCrossRef

Hettwer S, Wilhelm J, Schürmann M et al (2012) Microbial diagnostics in patients with presumed severe infection in the emergency department. Med Klinik Intensivmed Notflmed 107:53–62CrossRef

Howell MD, Donnino MW, Talmor D et al (2007) Performance of severity of illness scoring systems in emergency department patients with infection. Acad Emerg Med 14:709–714PubMedCrossRef

10.

Jones AE, Saak K, Kline JA (2008) Performance of the Mortality in emergency department sepsis score for predicting hospital mortality among patients with severe sepsis and septic shock. Am J Emerg Med 26:689–692PubMedCrossRef

11.

Jones AE, Trzeciak S, Kline JA (2009) The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 37:1649–1654PubMedCrossRef

12.

Knaus WA, Draper EA, Wagner DP et al (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829PubMedCrossRef

13.

Lee CC, Chen SY, Tsai CL et al (2008) Prognostic value of mortality in emergency department sepsis score, procalcitonin, and c-reactive protein in patients with sepsis at the emergency department. Shock 29:322–327PubMed

14.

Levy MM, Dellinger RP, Townsend SR et al (2010) The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 38:367–374PubMedCrossRef

15.

Majuran M, Clancy M (2008) Determination of the size of the different sepsis categories presenting to a UK teaching hospital emergency department. Emerg Med J 25:11–14PubMedCrossRef

16.

Milman N, Karsh J, Booth RA (2010) Correlation of a multi-cytokine panel with clinical disease activity in patients with rheumatoid arthritis. Clin Biochem 43:1309–1314PubMedCrossRef

17.

Moscovitz H, Shofer F, Mignott H et al (1994) Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 22:1102–1107PubMedCrossRef

18.

Nguyen HB, Banta JE, Cho TW et al (2008) Mortality predictions using current physiologic scoring systems in patients meeting criteria for early goal-directed therapy and the severe sepsis resuscitation bundle. Shock 30:23–28PubMedCrossRef

19.

Puskarich MA, Marchick MR, Kline JA et al (2009) One year mortality of patients treated with an emergency department based early goal directed therapy protocol for severe sepsis and septic shock: a before and after study. Crit Care 13:R167PubMedCrossRef

20.

Rezende E, Silva JM, Isola AM et al (2008) Epidemiology of severe sepsis in the emergency department and difficulties in the initial assistance. Clinics (Sao Paulo) 63:457–464

21.

Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377PubMedCrossRef

22.

Schuetz P, Christ-Crain M, Thomann R et al (2009) Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA 302:1059–1066PubMedCrossRef

23.

Shapiro NI, Wolfe RE, Moore RB et al (2003) Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med 31:670–675PubMedCrossRef

24.

Strehlow MC, Emond SD, Shapiro NI et al (2006) National study of emergency department visits for sepsis, 1992–2001. Ann Emerg Med 48:326–326PubMedCrossRef

25.

Viallon A, Guyomarc’h S, Marjollet O et al (2008) Can emergency physicians identify a high mortality subgroup of patients with sepsis: role of procalcitonin. Eur J Emerg Med 15:26–33PubMedCrossRef

26.

Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710PubMedCrossRef

27.

Vogt B, Fuhrnrohr B, Muller R et al (2007) CRP and the disposal of dying cells: consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity 40:295–298PubMedCrossRef

28.

Wang HE, Shapiro NI, Angus DC et al (2007) National estimates of severe sepsis in United States emergency departments. Crit Care Med 35:1928–1936PubMedCrossRef

29.

Werdan K, Pilz G, Bujdoso O et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35:2693–2701PubMedCrossRef

30.

Werdan K, Pilz G, Muller-Werdan U et al (2008) Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome-the ESSICS study. Crit Care Med 36:716–723PubMedCrossRef

Titel: Outcome prediction using clinical scores and biomarkers in patients with presumed severe infection in the emergency department
verfasst von: Dr. J. Wilhelm
S. Hettwer
D. Hammer
M. Schürmann
A. Christoph
M. Amoury
T. Klöss
R. Finke
H. Ebelt
K. Werdan
Publikationsdatum: 01.10.2012
Verlag: Springer-Verlag
Erschienen in: Medizinische Klinik - Intensivmedizin und Notfallmedizin / Ausgabe 7/2012
Print ISSN: 2193-6218
Elektronische ISSN: 2193-6226
DOI: https://doi.org/10.1007/s00063-012-0147-5

Neu im Fachgebiet AINS

11.04.2024 | Rückenschmerzen | Nachrichten

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Outcome prediction using clinical scores and biomarkers in patients with presumed severe infection in the emergency department

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet AINS

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Neue NIV-Leitlinie mit Anleitung zur Beatmungseinstellung vorgestellt

Update AINS

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2012

Schwere organische Dysphagie nach Langzeitbeatmung bei einem Patienten mit Sepsis und Multiorganversagen

Spontan bakterielle Peritonitis

Die schwierige Extubation

Terminankündigungen

Ethikvisite auf der Intensivstation

Update Tracheotomie

Neu im Fachgebiet AINS

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

Wie toxische Männlichkeit der Gesundheit von Männern schadet

Neue NIV-Leitlinie mit Anleitung zur Beatmungseinstellung vorgestellt

Update AINS